- Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia
-
Fernando EZ, Yu JRT, Santos SMA, Jamora RDG
- KMID: 2511492
- J Mov Disord.
- 2021 Jan;14(1):75-77.
- doi: 10.14802/jmd.20091
Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of... -
- CITED
-
- Close
- SHARE
-
- Close
